Low Dose Naltrexone for Multiple Sclerosis

New Book by Dr. Singleton
LDN Helps Fight Lyme!

Ad proceeds support
LDN education

Pain Treatment
Without Drugs
Proven by NASA

MS Helping Hands
MS Services & Resources in WA

Green For Good
A greener world, one step at a time

New Therapy for MS?

My name is SammyJo, I'm an MS patient who has experienced remarkable recovery from MS, thanks to the discovery by researchers that using a low dose of the FDA approved drug Naltrexone is helpful in treating many autoimmune disorders, including MS.

Visitors

Meet the LDN Advocates! Vicki Finlayson is walking 53 miles for LDN research May 19th!

SammyJo says:
Join the LDN Advocates!

Over 250 poll responses! See results

Get Free Research Polls

Not taking LDN,
show poll results.

Poll start 2/1/07

Speakers:
Vicki & SammyJo

Bill Wills, Pharmacist

Mary Anne Boyle Bradley
Author of
"Up The Creek
With A Paddle"

New LDN Book!
The Promise of Naltrexone
Potential Benefits of Low Dose Therapy for Patients with Cancer and Neurodegenerative and Autoimmune Disorders.

By Elaine Moore, co-author SammyJo Wilkinson, foreword by Dr. Yash Agrawal, MD

To be published by McFarland Sept, 2008
Sign Up to be notified when the book is published, and for LDN research alerts.

The off-label protocol referred to as Low Dose Naltrexone (LDN) modulates the immune system and promotes healing. Relying on clinical trial results and interviews with the leading LDN researchers worldwide, we describe the history of LDN and explain its biochemical and molecular effects. In clinical trials, LDN has been shown to halt disease progression in Crohn’s disease and certain cancers, including pancreatic cancer, and to reduce symptoms in multiple sclerosis (MS) and autism. Ongoing trials are evaluating LDN in fibromyalgia and HIV/AIDS. Anecdotally, LDN has been shown to improve every autoimmune and neurodegenerative condition, including Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

A BIG thank you to Elaine Moore for making this book a reality. She is an extensively published author on autoimmune disorders, this book will be an invaluable reference for researchers, practitioners and patients who want to understand the therapeutic potential of LDN.

Chapter One	The War on Drugs, A History of Naltrexone
Chapter Two	LDN in Autoimmune Diseases
Chapter Three	LDN in Multiple Sclerosis
Chapter Four	LDN in Neurodegenerative Disorders
Chapter Five	LDN in Cancer
Chapter Six	LDN in Autism Spectrum Disorders
Chapter Seven	LDN in Wound Healing and Infections
Chapter Eight	The Immune System and LDN in HIV/AIDS
Chapter Nine	The LDN Experience: A Patient’s Guide to LDN
Chapter Ten	The Potential Benefits and Future of LDN
Chapter Eleven	Resources
Appendix A	LDN Clinical Trials
Appendix B	LDN Survey
Appendix C	LDN Survey Analysis

Latest LDN News

Low Dose Naltrexone Update-The Benefits of LDN in Autoimmune Disease

Article by Elaine Moore

AHSTA - Alternative Health Solutions for Thyroid Autoimmunity w/ LDN topics

Ken Singleton, M.D. - How LDN helps fight Lyme

Media reports on LDN are picking up around the country in 2008

Research will be published on LDN in 2008! NMSS updates their opinion

Stanford's Clinical Trial of Naltrexone for Fibromyalgia Recruiting Patients
Story by Elaine Moore

LDN in the Treatment of HIV in Mali, Africa

The Use of LDN for MS, Crohn's, and Other Autoimmune Diseases
Article by Elaine Moore

WE DID IT !!!
The LDN for MS Research Fund raised $25,000
It has been awarded to the Univ. CA San Francisco MS Research Center.
A crossover study to evaluated the effect of LDN on MS has been completed on 80 patients with MS, to be published Spring '08. Show your Dr this study!

Press Release: Patient Advocates With Multiple Sclerosis Fund Clinical Trial of Promising Drug Many Say Has Helped; University of California, San Francisco MS Center to Conduct Study of Low-Dose Naltrexone

Thank you to individual contributors and those who put on fundraising events!

SammyJo, Vicki & Mary B

"An Evening at Lake of the Pines"

To Benefit the LDN research Fund and
Accelerated Cure Project for Multiple Sclerosis
hosted by Vicki Finlayson

September 17, 2006 4 p.m. Lake of the Pines Country Club Auburn, CA

LDN Fundraiser: Former firefighter Bill Roberts turned his life around in the past year with LDN. He has rallied his firefighter friends in the effort to get trials started to have the drug approved for treatment of Multiple Sclerosis.
Read more...

LDN Fundraiser: Sierra Doherty is hiking the Colorado Trail to raise money for LDN research! Her mom has MS and uses LDN. Click here to donate to her effort
-and get updates on Sierra's quest !

There are exciting developments in Low Dose Naltrexone (LDN) research. Visit the Research section for details on:

Publication of the first medical hypothesis on LDN therapy for MS

Status of clinical trials for LDN

2nd Annual LDN Conference Friday, April 7th Bethesda, Maryland
Conference registration fees were donated to the LDN for MS Research Fund!

First Annual LDN Conference June 11th 2005 in NYC
My Slides (PDF) | Dr. Skip's Slides | Conference Snapshots
Post conference summary | Dr Larry Frieders summary |Attendee commentary

Patient Initiated Research / Evidence-based Medicine

Four key questions answered by 267 LDN users in Survey 1:

Very low relapse rate of 0.2, or 1 in 5 years
70% report symptom improvement
45% think progression has stopped
76% say LDN is working for them, & will continue therapy

I started this site in the Spring of 2004 to confirm that others were seeing the same positive results I was. Thank you to the hundreds of LDNers contributing their experiences. I hope our efforts will soon become obsolete as the scientific research accelerates, but until then we will continue our patient tracking project.

Change in EDSS disability score before & after LDN is measured by Survey 2.

Follow the Surveys link for result details.

The surveys are comprised of a representative sampling of all types of MS (RRMS, SPMS, PPMS). This is important information from patients on the frontlines, and must be followed up by clinical researchers.

Naltrexone is an FDA-approved drug. LDN is an off-label use of naltrexone in a low dosage. It does requires a prescription from a doctor. See Resources for help finding a prescriber or pharmacy, or info on LDN for other autoimmune disorders, cancer or HIV.

"Never doubt that a small group of thoughtful committed citizens can change the world; indeed, it’s the only thing that ever has."
- Margaret Mead

GwenBaxter.com